A Risk-Benefit Assessment of Risperidone for the Treatment of Behavioural and Psychological Symptoms in Dementia

ISSN： 0114-5916

Source： Drug Safety, Vol.23, Iss.3, 2000-09, pp. : 183-195

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Risperidone for behavioural and psychological symptoms of dementia

Inpharma, Vol. 1, Iss. 1361, 2002-01 ,pp. : 11-13

Adis International

Access to resources Recommend Favorite

Risperidone: A Review of its Use in the Management of the Behavioural and Psychological Symptoms of Dementia

By Bhana N. Spencer C.M.

Drugs & Aging, Vol. 16, Iss. 6, 2000-06 ,pp. : 451-471

Adis International

Access to resources Recommend Favorite

A Risk-Benefit Assessment of Sildenafil in the Treatment of Erectile Dysfunction

By Vitezic D.

Drug Safety, Vol. 24, Iss. 4, 2001-01 ,pp. : 255-265

Adis International

Access to resources Recommend Favorite

A Risk-Benefit Assessment of Alendronate in the Treatment of Involutional Osteoporosis

By Devogelaer J-P.

Drug Safety, Vol. 19, Iss. 2, 1998-08 ,pp. : 141-154

Adis International

Access to resources Recommend Favorite

Use of Gabapentin in the Treatment of Behavioural and Psychological Symptoms of Dementia: A Review of the Evidence

By Kim Yunie Wilkins Kirsten M. Tampi Rajesh R.

Drugs & Aging, Vol. 25, Iss. 3, 2008-01 ,pp. : 187-196

Adis International

Access to resources Recommend Favorite